The coronavirus disease 2019 (COVID-19) is a great challenge to medical systems in affected countries. As COVID-19 came to public attention, researchers want to learn more about its spread, mortality rate, and who is most susceptible to have severe disease.
Elderly and those with other comorbidities are at the high of a severe illness. Until now, it is still uncertain of how much chronic hepatic diseases are referred to as risk factors, because of a deficiency of researches. Bacterial infections are very common in cirrhotic patients and lead to increase complications and mortality. Spontaneous bacterial peritonitis (SBP) is one of the most common complications in cirrhotic patients.
Corona is not only controlling the media; but also, is making doctors worrying about its direct effect on the hepatic patient. As well, this pandemic necessitates the special arrangement of medical resources that can affect hepatic patients who continue to require medical care. So, we aimed to discuss some information and guidance for managing SBP patients during the COVID-19 pandemic.